ResearcherSun Yat-sen UniversityNo recent work listed
Jinsheng Huang
Matched on ORCID iD 0000-0002-5859-4994; OpenAlex author ID A5012285236. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2023: 4 papers
Papers 4
- Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian popu… Co-author DOI 10.1002/cam4.6057↗
- Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and networ… First author DOI 10.1007/s00228-022-03441-9↗
- Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metastasis and a Nomogram Prediction Model for … Co-author DOI 10.1155/2023/2916974↗
- Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer. First author DOI 10.1177/17588359231186029↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xujia Li · 4 shared papers, 2023 · strength 0.80
- Paper Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metasta… DOI 10.1155/2023/2916974↗
- Paper Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer. DOI 10.1177/17588359231186029↗
- Paper Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization … DOI 10.1002/cam4.6057↗
- Guifang Guo · 4 shared papers, 2023 · strength 0.80
- Paper Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metasta… DOI 10.1155/2023/2916974↗
- Paper Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer. DOI 10.1177/17588359231186029↗
- Paper Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization … DOI 10.1002/cam4.6057↗
- Shengping Li · 2 shared papers, 2023 · strength 0.40
- Bokang Cui · 1 shared paper, 2023 · strength 0.20
- Feng‐Hua Wang · 1 shared paper, 2023 · strength 0.20
- Qi Quan · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.